z-logo
Premium
Identification of the dopamine autoreceptor in the guinea‐pig retina as D 2 receptor using novel subtype‐selective antagonists
Author(s) -
Weber Bernd,
Schlicker Eberhard,
Sokoloff Pierre,
Stark Holger
Publication year - 2001
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0704192
Subject(s) - autoreceptor , dopamine , endocrinology , quinpirole , medicine , haloperidol , dopamine receptor , chemistry , dopamine receptor d2 , receptor , dopamine receptor d3 , agonist , biology
Dopamine release in the retina is subject to modulation via autoreceptors, which belong to the D 2 receptor family (encompassing the D 2 , D 3 and D 4 receptors). The aim of the present study was to determine the receptor sub type (D 2 vs D 3 ) involved in the inhibition of dopamine release in guinea‐pig retinal discs, using established (haloperidol, ( S )‐nafadotride) and novel dopamine receptor antagonists (ST‐148, ST‐198). hD 2L and hD 3 receptors were expressed in CHO cells and the p K i values determined in binding studies with [ 125 I]‐iodosulpride were: haloperidol 9.22 vs 8.54; ST‐148 7.85 vs 6.60; ( S )‐nafadotride 8.52 vs 9.51; ST‐198 6.14 vs 7.92. The electrically evoked tritium overflow from retinal discs preincubated with [ 3 H]‐noradrenaline (which represents quasi‐physiological dopamine release) was inhibited by the dopamine receptor agonists B‐HT 920 (talipexole) and quinpirole (maximally by 82 and 71%; pEC 50 5.80 and 5.83). The concentration‐response curves of these agonists were shifted to the right by haloperidol (apparent pA 2 8.69 and 8.23) and ST‐148 (7.52 and 7.66). ( S )‐Nafadotride 0.01 μ M and ST‐198 0.32 μ M did not affect the concentration‐response curve of B‐HT 920. The dopamine autoreceptor in the guinea‐pig retina can be classified as a D 2 receptor. ST‐148 and ST‐198 show an improved selectivity for D 2 and D 3 receptors when compared to haloperidol and ( S )‐nafadotride, respectively.British Journal of Pharmacology (2001) 133 , 1243–1248; doi: 10.1038/sj.bjp.0704192

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom